Scott Crowe

This inventor holds 13 USPTO granted patents and 10 published patent applications and 3 EPO patents. Top assignees: Sorriso Pharmaceuticals, Inc., Vhsquared Limited. Active years: 2020-2026.

USPTO Granted Patents = 13 (Patent Applications = 10)

% Patents Active = 100.0

EPO Patents = 3 (Patent Applications = 11)

Average Co-Inventor Count = 6.5

ph-index = 3

Forward Citations = 29(Granted Patents)

Location History:

Babraham, GB (2021 - 2022)
Cambridge, GB (2020 - 2023)

Company Filing History:

10 out of 10

Sorriso Pharmaceuticals, Inc.

Years Active: 2020-2026

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12570736 - COMPOSITIONS (2026-03-10),

2. 12559552 - IL-23 and TNF-alpha binding Bi-specific Heavy Chain Polypeptides (2026-02-24),

3. 12247079 - Polynucleotides encoding, and method of making, a polypeptide comprising a VHH which binds interleukin-receptor (IL-7R) (2025-03-11),

4. 12234279 - Peptide construct having a protease-cleavable linker (2025-02-25),

5. 12173054 - Polypeptides (2024-12-24),

6. 12098197 - Polypeptides comprising immunoglobulin chain variable domains which bind to interleukin-6 receptor (IL-6R) and methods of use thereof to treat autoimmune and inflammatory diseases (2024-09-24),

7. 11684677 - Compositions (2023-06-27),

8. 11667719 - VHH immunoglobulin chain variable domain that binds to IL-7R and methods of use thereof for treating autoimmune and/or inflammatory diseases (2023-06-06),

9. 11623952 - IL-23 and TNF-alpha binding bi-specific heavy chain polypeptides (2023-04-11),

10. 11401327 - Polypeptides which bind to interleukin-6 receptor (IL-6R) (2022-08-02),

11. 10980748 - Compositions (2021-04-20),

12. 10772839 - Compositions (2020-09-15),

13. 10633438 - Polypeptides (2020-04-28),

Title: Scott Crowe: Innovator in Biopharmaceuticals

Introduction

Scott Crowe is a notable inventor based in Babraham, GB. He has made significant contributions to the field of biopharmaceuticals, holding a total of 13 patents. His work primarily focuses on polypeptides and their applications in medical treatments.

Latest Patents

Among his latest patents is a groundbreaking invention related to polynucleotides encoding and methods for creating polypeptides that bind to the interleukin-receptor (IL-7R). This invention includes polypeptides capable of inhibiting IL-7 and/or L-TSLP binding to IL-7R, along with constructs and pharmaceutical compositions that utilize these polypeptides. Another notable patent involves a peptide construct featuring a protease-cleavable linker, designed for oral administration. This construct comprises two polypeptides connected by a labile peptide linker, which is sensitive to proteases found in the intestinal tract, while the polypeptides themselves remain resistant to these enzymes.

Career Highlights

Scott has worked with several companies throughout his career, including Sorriso Pharmaceuticals, Inc. and Vhsquared Limited. His experience in these organizations has allowed him to develop innovative solutions in the biopharmaceutical sector.

Collaborations

Scott has collaborated with notable professionals in his field, including Mike West and Kevin Roberts. Their combined expertise has contributed to the advancement of his research and inventions.

Conclusion

Scott Crowe is a distinguished inventor whose work in biopharmaceuticals has led to significant advancements in medical treatments. His innovative patents and collaborations highlight his commitment to improving healthcare through scientific research.